Anders Hamsten Selected Research

Biomarkers (Surrogate Marker)

11/2018	Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders.
4/2017	Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.
12/2016	PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.
6/2015	Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.
3/2015	Plasma IL-5 concentration and subclinical carotid atherosclerosis.
1/2015	Analysis of the role of interleukin 6 receptor haplotypes in the regulation of circulating levels of inflammatory biomarkers and risk of coronary heart disease.
10/2014	miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.
6/2014	A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness).
11/2013	Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis.
4/2012	Association of a sequence variant in DAB2IP with coronary heart disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Hamsten Research Topics

Disease

35	Atherosclerosis 12/2021 - 09/2002
27	Inflammation (Inflammations) 01/2020 - 05/2003
27	Coronary Artery Disease (Coronary Atherosclerosis) 05/2016 - 05/2002
27	Myocardial Infarction 03/2015 - 05/2002
19	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 03/2004
17	Coronary Disease (Coronary Heart Disease) 01/2018 - 04/2003
17	Insulin Resistance 10/2016 - 06/2004
15	Obesity 03/2016 - 09/2004
14	Thrombosis (Thrombus) 01/2017 - 07/2005
13	Type 2 Diabetes Mellitus (MODY) 09/2017 - 04/2003
8	Atherosclerotic Plaque (Atheroma) 01/2020 - 07/2003
6	Venous Thromboembolism 12/2016 - 05/2008
6	Abdominal Aortic Aneurysm 08/2012 - 03/2004
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2009 - 12/2005
5	Ischemic Stroke 01/2019 - 08/2005
5	Hypertension (High Blood Pressure) 03/2016 - 03/2002
5	Diabetes Mellitus 03/2016 - 03/2002
5	Hepatocellular Carcinoma (Hepatoma) 06/2014 - 08/2003
4	Rheumatoid Arthritis 01/2014 - 06/2004
4	Stroke (Strokes) 09/2013 - 08/2005
4	Lipodystrophy 07/2008 - 04/2003
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 12/2003
3	Carotid Artery Diseases 03/2015 - 02/2013
3	Body Weight (Weight, Body) 01/2015 - 04/2005
3	Vascular Diseases (Vascular Disease) 08/2012 - 01/2007
3	Aneurysm (Aneurysms) 08/2012 - 07/2005
3	Hypercholesterolemia 03/2008 - 03/2002
2	Glucose Intolerance 01/2021 - 10/2003
2	Hyperplasia 01/2020 - 01/2016
2	Vascular Remodeling 01/2020 - 02/2015
2	Necrosis 01/2018 - 02/2009
2	Overweight 03/2016 - 04/2005
2	Thrombophilia 01/2016 - 08/2012
2	Thromboembolism 01/2016 - 08/2014
2	Infarction (Infarctions) 03/2015 - 09/2008
2	Autoimmune Diseases (Autoimmune Disease) 03/2015 - 04/2011
2	Hypersensitivity (Allergy) 03/2015 - 12/2006
2	Cardiomegaly (Heart Hypertrophy) 02/2015 - 01/2014

Drug/Important Bio-Agent (IBA)

17	LipidsIBA 01/2016 - 04/2003
16	Insulin (Novolin)FDA Link 01/2021 - 02/2006
14	Lipoproteins (Lipoprotein)IBA 06/2014 - 03/2002
13	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2002
13	Triglycerides (Triacylglycerol)IBA 03/2016 - 03/2002
12	Biomarkers (Surrogate Marker)IBA 11/2018 - 05/2003
12	C-Reactive ProteinIBA 11/2018 - 05/2003
11	Interleukin-6 (Interleukin 6)IBA 01/2020 - 05/2003
11	Proteins (Proteins, Gene)FDA Link 04/2017 - 09/2004
9	Messenger RNA (mRNA)IBA 09/2014 - 01/2006
8	CholesterolIBA 02/2014 - 04/2005
7	Apolipoprotein B-100 (Apo B 100)IBA 09/2014 - 08/2007
7	LDL Lipoproteins (beta Lipoproteins)IBA 11/2013 - 05/2002
7	ApolipoproteinsIBA 03/2009 - 09/2002
6	AutoantibodiesIBA 01/2022 - 04/2003
6	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 09/2002
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2016 - 06/2004
6	Hormones (Hormone)IBA 01/2016 - 01/2007
6	Fibrinogen (Factor I)FDA Link 09/2013 - 12/2004
6	oxidized low density lipoproteinIBA 03/2008 - 04/2003
5	HDL CholesterolIBA 03/2016 - 11/2007
5	LDL CholesterolIBA 03/2016 - 05/2002
5	Plasminogen Activator Inhibitor 1IBA 01/2012 - 04/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2009 - 07/2006
4	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 07/2005
4	Factor VII (Proconvertin)IBA 01/2019 - 02/2005
4	Biological ProductsIBA 10/2018 - 08/2012
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018 - 03/2012
4	InterleukinsIBA 01/2018 - 10/2006
4	AdiponectinIBA 08/2015 - 07/2006
4	HDL LipoproteinsIBA 11/2013 - 07/2003
4	Fatty Acids (Saturated Fatty Acids)IBA 05/2008 - 01/2006
3	Blood Proteins (Serum Proteins)IBA 01/2021 - 09/2010
3	AntibodiesIBA 12/2016 - 09/2008
3	Thrombin FDA Link 01/2016 - 12/2007
3	Immunoglobulin G (IgG)IBA 03/2015 - 03/2008
3	SaltsIBA 02/2015 - 12/2011
3	Small Interfering RNA (siRNA)IBA 06/2014 - 03/2008
3	25-hydroxyvitamin DIBA 06/2014 - 07/2012
3	hydroxide ionIBA 06/2014 - 07/2012
3	O(4)-methylthymidine triphosphateIBA 02/2014 - 03/2008
3	HomocysteineIBA 09/2013 - 04/2009
3	Apolipoproteins E (ApoE)IBA 05/2013 - 09/2002
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2012 - 05/2009
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2012 - 04/2003
3	PPAR gammaIBA 11/2007 - 08/2003
3	Rosiglitazone (Avandia)FDA Link 02/2007 - 04/2003
2	Metalloproteases (Metalloproteinases)IBA 01/2020 - 07/2008
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2020 - 12/2016
2	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 05/2005
2	ProinsulinIBA 11/2017 - 10/2011
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2017 - 08/2012
2	Interleukin-5 (Interleukin 5)IBA 05/2016 - 03/2015
2	Proprotein Convertase 9IBA 03/2016 - 06/2012
2	Lipoprotein(a)IBA 03/2016 - 08/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2015 - 05/2008
2	Immunoglobulin M (IgM)IBA 03/2015 - 09/2008
2	Endothelin-1 (Endothelin 1)IBA 02/2015 - 05/2003
2	Phosphotransferases (Kinase)IBA 02/2015 - 01/2014

Therapy/Procedure

4	Highly Active Antiretroviral Therapy (HAART) 07/2008 - 04/2003
4	Therapeutics 03/2008 - 04/2003
2	Glycemic Control 09/2017 - 10/2015